Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Lands GSA Contract, Opens Way for New Gov't Deals; Shares Surge 33 Percent

NEW YORK (GenomeWeb News) — Nanogen can sell its NanoChip 400 microarray and reagents to government departments under a US Government Service Administration contract, the company said today.
Nanogen said the GSA schedule vendor contract will allow it to sell the microarray technology and reagents directly to the National Institutes of Health, Veteran’s Administration hospitals, and military hospitals.
According to Nanogen, because government agencies have separate budgets for GSA-approved vendors, its government customers will be able to buy its products more expediently using a wider pool of funds.
News of the arrangement caused shares in Nanogen to climb 33.33 percent, or $.42, to $1.68 in mid-afternoon trading today.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.